Atlas Capital Advisors LLC Genmab A/S Transaction History
Atlas Capital Advisors LLC
- $788 Billion
- Q4 2024
A detailed history of Atlas Capital Advisors LLC transactions in Genmab A/S stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 189 shares of GMAB stock, worth $3,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189
Previous 189
-0.0%
Holding current value
$3,749
Previous $4.61 Million
14.39%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
61.3MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$296 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$101 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$61.3 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$55.9 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$55.7 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.1B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...